Please use this identifier to cite or link to this item:
Title: Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvant treatment, in patients with high-risk colon cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Antimetabolites, Antineoplastic/administration & dosage,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Colonic Neoplasms/*drug therapy/pathology,Disease-Free Survival,Female,Fluorouracil/administration & dosage,Humans,Interferon-alpha/administration & dosage/adverse effects/*therapeutic use,Leucovorin/administration & dosage,Male,Middle Aged,Neoplasm Staging,Prognosis,Recombinant Proteins,Survival Analysis,Treatment Outcome
ISSN: 0030-2414
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Fountzilas-2000-Fluorouracil and leu.pdf339.28 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons